AzTrials
AzTrials

RadiculopathyNCT02196883

Steroid Injections Given at the "Level of MRI Pathology" Versus at the "Level of Clinical Symptoms" to See if One is More Effective Than the Other.

A study testing Transforaminal Epidural Steroid Injection in people with Radiculopathy and Spinal Stenosis, run by State University of New York - Upstate Medical University at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Patients are being asked to participate in a research study because the patients are being treated for low back pain and the patients have decided to have an epidural steroid injection. Low back pain has a tremendous impact on the individual and society. Read more about this study

Who is it for?
Ages 21 years and older
What is being tested?
Transforaminal Epidural Steroid Injection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
May 2014to May 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Adult, Older adult

Who may be able to join

  • Diagnosis of Single level spinal stenosis.
  • Single level radiculopathy with MRI findings at a different level than clinical pattern.
  • Chronic low back pain with radicular symptoms of > 4 weeks, but < 6 months.
  • Failure of conservative therapy to include physical and pharmacotherapy.
  • Patient is at least 21 years of age.
  • Patient is willing to be blinded to treatment until after the 3-month follow up visit.
  • Patient is willing and able to review and sign the study's informed consent form.

Who cannot join

  • Patient has a mental or physical condition that would invalidate evaluation results.
  • Patient has had prior lumbar surgery at any level.
  • Patient is pregnant.
  • Patient has systemic infection or infection at the proposed injection site.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • SUNY Upstate Medical Center

    Syracuse, New York, 13210

Other trials in United States

About this study

Official title: A Prospective, Randomized, Single Blind Study Comparing Transforaminal Epidural Steroid Injections at the Level of MRI Pathology vs Clinical Symptoms

Patients are being asked to participate in a research study because the patients are being treated for low back pain and the patients have decided to have an epidural steroid injection.

Low back pain has a tremendous impact on the individual and society. It not only affects the individuals quality of life, it also contributes to lost productivity and increased health care costs.

Read more

Epidural steroid injections (ESIs) are a common treatment option for many forms of low back pain. They have been used for low back problems since 1952 and are still being used as a non-surgical form of treatment for low back pain. The goal of the injections is reduction of pain, increased quality of life and improved function.

This study is being conducted to determine the outcomes of injections given at the "level of MRI Pathology" versus at the "level of clinical symptoms" to see if one is more effective than the other and to learn more about the characteristics of the two different injections.

Being tested
Transforaminal Epidural Steroid Injection
Medical subject headings
Radiculopathy, Spinal Stenosis, Intervertebral Disc Displacement

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transforaminal Epidural Steroid InjectionProcedure or surgery

Study groups in NCT02196883
Study groupRoleWhat they receive
MRI PathologyActive comparatorNot described
Receives: Procedure: Transforaminal Epidural Steroid Injection
Physical Exam PathologyActive comparatorNot described
Receives: Procedure: Transforaminal Epidural Steroid Injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale

    Measured: 2 weeks to 6months

Secondary outcomes (2)
  1. Short Form 36 Health Survey

    Measured: 2 weeks to 6months

  2. Oswestry Disability Index

    Measured: 2 weeks to 6months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2014 (estimated)
  2. Study startMay 2014
  3. Primary completionMay 2015 (estimated)

Why it stopped: PI no longer part of practice

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02196883
Sponsor's protocol ID
593154-1
Status last verified
Jul 2014
First submitted
18 Jul 2014
Last updated
14 Jun 2016
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Transforaminal Epidural Steroid Injection in people with Radiculopathy and Spinal Stenosis, run by State University of New York - Upstate Medical University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 14 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (time frame: 2 weeks to 6months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in